Table 5.

Prevalence of comorbid conditions, selected behavioural characteristics, medications used, signs and symptoms, and self-reported health in the SaMi-Trop cohort.

Variables	Valid N	N	Per cent
Comorbid conditions	1.959
High serum cholesterol		785	40.1
Hypertension		706	36.0
Diabetes mellitus		198	10.1
Thyroid disorder		159	8.1
Kidney disease		143	7.3
Leishmaniosis		22	1.2
Behavioural characteristics	1.945
Physical activity last week (minimal 30 min)		434	22.3
Alcohol last month		318	16.2
Current smoking		143	7.3
Number of medicine in use	1.959
0		589	30.1
1–2		714	36.4
3–4		538	27.5
≥5		118	6.0
Medicine in use (yes)	1.940
Diuretics		951	49.1
ACE		553	28.6
ARBs		550	28.4
Aspirin		507	26.2
Amiodarone		429	22.0
Carvedilol		380	19.6
Digoxin		140	7.2
β-blockers		140	7.2
Vasodilators		84	4.3
Warfarin		11	0.6
Signs and symptoms or self-reported conditions (yes)	1.924
Heartbeat racing or beating abnormally		1.222	63.5
Prolonged faintness or dizziness		1.203	62.5
Problems on ECG		1.180	61.3
Heart palpitations		1.174	61.0
Short of breath during physical exercises		1.143	59.4
Heartbeat racing at rest		1.015	52.8
Heartbeat not regular		902	46.9
Difficulty breathing when lying down		752	39.1
Unable to climb two flights of stairs		749	38.9
Awake during the night unable to breath		683	35.5
Trouble swallowing		599	31.1
Swelling or puffiness of the feet in the morning		502	26.1
No bowel movement for three or more days		478	24.8
Fainting or loss of consciousness		429	22.0
Visible neck veins when standing up or sitting		409	21.3
Pain when swallowing food		342	17.8
Pacemaker		110	6.2
Megaesophagus		117	6.1

ARBs, angiotensin receptor blockers; SaMi-Trop, São Paulo-Minas Gerais Tropical Medicine Research Center.